140 related articles for article (PubMed ID: 22363123)
1. Leptin and peroxisome proliferator-activated receptor γ expression in colorectal adenoma.
Kim HH; Kim YS; Kang YK; Moon JS
World J Gastroenterol; 2012 Feb; 18(6):557-62. PubMed ID: 22363123
[TBL] [Abstract][Full Text] [Related]
2. [The difference of clinicopathologic features according to leptin expression in colorectal adenoma].
Ok KS; Kim YS; Kim HH; Ryu SH; Lee JH; Moon JS; Kang YK
Korean J Gastroenterol; 2010 Jul; 56(1):20-6. PubMed ID: 20664314
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of PCNA and CD34 in colorectal adenomas and carcinomas using specified automated cellular image analysis system: a clinicopathologic study.
Qasim BJ; Ali HH; Hussein AG
Saudi J Gastroenterol; 2012; 18(4):268-76. PubMed ID: 22824771
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of peroxisome proliferator-activated receptor γ is a biomarker for colorectal cancer progression and adverse patients' outcome.
Pancione M; Sabatino L; Fucci A; Carafa V; Nebbioso A; Forte N; Febbraro A; Parente D; Ambrosino C; Normanno N; Altucci L; Colantuoni V
PLoS One; 2010 Dec; 5(12):e14229. PubMed ID: 21151932
[TBL] [Abstract][Full Text] [Related]
5. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
[TBL] [Abstract][Full Text] [Related]
6. UHRF1 coordinates peroxisome proliferator activated receptor gamma (PPARG) epigenetic silencing and mediates colorectal cancer progression.
Sabatino L; Fucci A; Pancione M; Carafa V; Nebbioso A; Pistore C; Babbio F; Votino C; Laudanna C; Ceccarelli M; Altucci L; Bonapace IM; Colantuoni V
Oncogene; 2012 Dec; 31(49):5061-72. PubMed ID: 22286757
[TBL] [Abstract][Full Text] [Related]
7. Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication.
Uddin S; Bavi PP; Hussain AR; Alsbeih G; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Ahmed M; Al-Kuraya KS
Carcinogenesis; 2009 Nov; 30(11):1832-40. PubMed ID: 19520793
[TBL] [Abstract][Full Text] [Related]
8. Itaconate and leptin affecting PPARγ in M2 macrophages: A potential link to early-onset colorectal cancer.
Scheurlen KM; Snook DL; Walter MN; Cook CN; Fiechter CR; Pan J; Beal RJ; Galandiuk S
Surgery; 2022 Mar; 171(3):650-656. PubMed ID: 34876290
[TBL] [Abstract][Full Text] [Related]
9. Role of the long form leptin receptor and of the STAT3 signaling pathway in colorectal cancer progression.
Uchiyama T; Takahashi H; Endo H; Sugiyama M; Sakai E; Hosono K; Nagashima Y; Inayama Y; Wada K; Hippo Y; Nakajima A
Int J Oncol; 2011 Oct; 39(4):935-40. PubMed ID: 21720710
[TBL] [Abstract][Full Text] [Related]
10. AMACR is associated with advanced pathologic risk factors in sporadic colorectal adenomas.
Lakis S; Papamitsou T; Panagiotopoulou C; Kotakidou R; Kotoula V
World J Gastroenterol; 2010 May; 16(20):2476-83. PubMed ID: 20503447
[TBL] [Abstract][Full Text] [Related]
11. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
Pancione M; Forte N; Sabatino L; Tomaselli E; Parente D; Febbraro A; Colantuoni V
Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
[TBL] [Abstract][Full Text] [Related]
12. Correlation of epidermal growth factor receptor with morphological features of colorectal advanced adenomas: a pilot correlative case series.
Bansal A; Liu X; McGregor DH; Singh V; Hall S
Am J Med Sci; 2010 Oct; 340(4):296-300. PubMed ID: 20622650
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of blood leptin concentration and colonic mucosa leptin expression in colon adenoma patients and healthy control].
Oh JS; Kim HH; Hwang HS; Yun DY; Kim BS; Lee CH; Han J; Kim HG; Jung JT; Kwon JG; Kim EY
Korean J Gastroenterol; 2014 Jun; 63(6):354-60. PubMed ID: 24953612
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis.
Maver A; Medica I; Salobir B; Tercelj-Zorman M; Sabovic M; Petrovic D; Peterlin B
Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep; 25(1):29-35. PubMed ID: 19070258
[TBL] [Abstract][Full Text] [Related]
15. Leptin receptor is involved in STAT3 activation in human colorectal adenoma.
Uchiyama T; Takahashi H; Sugiyama M; Sakai E; Endo H; Hosono K; Yoneda K; Yoneda M; Inamori M; Nagashima Y; Inayama Y; Wada K; Nakajima A
Cancer Sci; 2011 Feb; 102(2):367-72. PubMed ID: 21166956
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon.
Herszényi L; Sipos F; Galamb O; Solymosi N; Hritz I; Miheller P; Berczi L; Molnár B; Tulassay Z
Pathol Oncol Res; 2008 Mar; 14(1):31-7. PubMed ID: 18347934
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor γ coactivator-1α is a predictor of lymph node metastasis and poor prognosis in human colorectal cancer.
Yun SH; Roh MS; Jeong JS; Park JI
Ann Diagn Pathol; 2018 Apr; 33():11-16. PubMed ID: 29566941
[TBL] [Abstract][Full Text] [Related]
18. Changes in gene expression profile in human subcutaneous adipose tissue during significant weight loss.
Leyvraz C; Verdumo C; Suter M; Paroz A; Calmes JM; Marques-Vidal PM; Giusti V
Obes Facts; 2012; 5(3):440-51. PubMed ID: 22797372
[TBL] [Abstract][Full Text] [Related]
19. An immunohistochemical study of Ki-67 in colorectal adenoma.
Radovanovic-Dinic B; Nagorni A; Katic V; Stamenkovic I; Zlatic A
Med Arh; 2009; 63(1):16-8. PubMed ID: 19419120
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-gamma expression in the lung tissue of obese rats.
Hwang SJ; Kim JH; Shim JW; Kim DS; Jung HL; Park MS; Lee WY; Kim SY; Shim JY
Yonsei Med J; 2011 May; 52(3):495-501. PubMed ID: 21488194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
